1.
Pediatr Infect Dis J
; 38(3): e51-e53, 2019 03.
Article
in English
| MEDLINE
| ID: mdl-29601455
ABSTRACT
We report on the successful treatment of a South African infant with hepatitis B virus (HBV)-induced acute liver failure using lamivudine with no evidence of clinical resistance. Perinatal HBV transmission occurred despite timely HBV vaccination at 6, 10 and 14 weeks, as per South African vaccination schedule, highlighting the need to introduce the birth-dose HBV vaccine in South Africa.